Spyre Therapeutics Advances SPY772 into Phase 2 for Hidradenitis Suppurativa
Waltham, Mass., August 10, 2026 Spyre Therapeutics, Inc. announced the launch of its SPY772 combination program and initiation of...
machine learning
Advertisement
Novo Nordisk and AWS Partner to Accelerate AI Drug Discovery
Bagsværd, Denmark, August 10, 2026 Novo Nordisk and Amazon Web Services (AWS) announced a strategic partnership aimed at accelerating...
Bristol Myers Squibb Expands AI Collaboration with NVIDIA
PRINCETON, N.J., July 20, 2026 Bristol Myers Squibb (BMS) announced a major expansion of its strategic collaboration with NVIDIA...
Chai Discovery Secures $400M to Transform AI Drug Discovery
SAN FRANCISCO, July 17, 2026 Chai Discovery has announced the successful completion of a $400 million Series C financing...
Freenome Reports Strong SimpleScreen CRC Study Results
BRISBANE, Calif. | July 9, 2026 Freenome, an early cancer detection company advancing blood-based cancer screening technologies, has announced...
Advertisements
Aureka Launches OpenDDE to Advance AI Drug Discovery
LAGUNA HILLS, California & SHANGHAI, China, July 6, 2026 Aureka, an AI TechBio company developing next-generation infrastructure for AI-driven...
PolarityBio Submits FDA BLA for SkinTE in Diabetic Foot Ulcers
SALT LAKE CITY, Utah, July 1, 2026 PolarityBio has announced the submission of a Biologics License Application (BLA) to...
Insilico Secures Up to $600M Takeda AI Discovery Deal
CAMBRIDGE, Mass., July 2, 2026 Insilico Medicine has entered into a strategic collaboration with Takeda to accelerate the discovery...
BillionToOne Northstar Response® Advances Cancer Monitoring
MENLO PARK, Calif., June 29, 2026 BillionToOne has announced the publication of a peer-reviewed clinical study demonstrating that its...
Inductive Bio Brings AI-Powered ADMET Models to Claude
NEW YORK, June 30, 2026 Inductive Bio, Inc. has announced its integration into Anthropic’s Connector Ecosystem for Life Sciences,...
Advertisement
